Biologics Contract Manufacturing Market
Biologics Contract Manufacturing Market Scope: Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
Biologics Contract Manufacturing Market Size and Growth
The Biologics Contract Manufacturing market is experiencing significant growth, driven by increasing demand for biologics, advancements in technology, and rising outsourcing trends. The market size is projected to reach approximately $9.5 billion by 2025, reflecting a compound annual growth rate (CAGR) of around 8%. Competitive dynamics and regulatory challenges remain key considerations. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Wuxi Biologics
◍ Abzena Ltd.
◍ FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
◍ Boehringer Ingelheim GmbH
◍ Lonza
◍ SamsungBiologics
◍ Abbvie
◍ Catalent
◍ Bioreliance
◍ Thermo Fischer (Patheon)
◍ Eurofins CDMO
The Biologics Contract Manufacturing Market features key players like Wuxi Biologics, Abzena, FUJIFILM Diosynth, Boehringer Ingelheim, Lonza, Samsung Biologics, Abbvie, Catalent, Bioreliance, and Thermo Fisher. These companies provide advanced manufacturing, enhance scalability, and optimize production efficiency, driving market growth. Sales revenues include:
- Lonza: $6+ billion
- Samsung Biologics: $1.5 billion
- Boehringer Ingelheim: $19 billion (total revenue, including biologics)
Request Sample Report
Market Segmentation
By Application
◍ Immunological Disorders
By Product
MABs
◍ Recombinant Protein ◍ Others ◍ Oncology
◍ Cardiovascular Disorders (CVDs)
◍ Hematological Disorders
◍ Others Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
